MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers

Cancer Research

Volumn 71, Issue 5, 2011, Pages 1680-1689

  Sakurai, Kouhei ^a   Furukawa, Chihiro ^a   Haraguchi, Takeshi ^a   Inada, Ken Ichi ^b   Shiogama, Kazuya ^b   Tagawa, Takanobu ^a   Fujita, Shuji ^a   Ueno, Yoshihito ^c,d   Ogata, Aya ^c   Ito, Mai ^b   Tsutsumi, Yutaka ^b   Iba, Hideo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRM PROTEIN; MESSENGER RNA; MICRORNA; PROTEIN SWI; TRANSCRIPTION FACTOR EGR 1; TRANSCRIPTION FACTOR SNF;

3' UNTRANSLATED REGION; ARTICLE; CARCINOGENESIS; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE; GENE EXPRESSION; GENE LOCUS; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TUMOR CELL LINE; UPREGULATION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EARLY GROWTH RESPONSE PROTEIN 1; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 79952228130     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2345     Document Type: Article

References (39)

1. Gebuhr TC, Bultman SJ, Magnuson T. Pc-G/trx-G and the SWI/SNF connection: developmental gene regulation through chromatin remodeling. Genesis 2000;26:189-97. (Pubitemid 30194545)
2. Muchardt C,, Yaniv M. When the SWI/SNF complex remodels . . . the cell cycle. Oncogene 2001;20:3067-75.
3. Phelan ML, Sif S, Narlikar GJ, Kingston RE. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 1999;3:247-53. (Pubitemid 29292625)
4. Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nat Genet 1999;22:102-5. (Pubitemid 29214815)
5. Kowenz-Leutz E,, Leutz A. A C/EBP beta isoform recruits the SWI/ SNF complex to activate myeloid genes. Mol Cell 1999;4:735-43.
6. Ito T, Yamauchi M, Nishina M, Yamamichi N, Mizutani T, Ui M, et al. Identification of SWI.SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun dimers. J Biol Chem 2001;276:2852-7.
7. Yamamichi N, Inada K, Furukawa C, Sakurai K, Tando T, Ishizaka A, et al. Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells. Exp Cell Res 2009;315:1779-89.
8. Oh J, Sohn DH, Ko M, Chung H, Jeon SH, Seong RH. BAF60a interacts with p53 to recruit the SWI/SNF complex. J Biol Chem 2008;283:11924-34.
9. Tando T, Ishizaka A, Watanabe H, Ito T, Iida S, Haraguchi T, et al. Requiem protein links RelB/p52 and the Brm-type SWI/SNF complex in a noncanonical NF-kappaB pathway. J Biol Chem 2010;285: 21951-60.
10. Watanabe H, Mizutani T, Haraguchi T, Yamamichi N, Minoguchi S, Yamamichi-Nishina M, et al. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines. Oncogene 2006;25:470-9. (Pubitemid 43117632)
11. Harikrishnan KN, Chow M Z, Baker EK, Pal S, Bassal S, Brasacchio D, et al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 2005;37:254-64.
12. Sudarsanam P,, Winston F. The SWI/SNF family nucleosome-remodeling complexes and transcriptional control. Trends Genet 2000; 16:345-51. (Pubitemid 30628835)
13. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 2000;6:1287-95. (Pubitemid 32045922)
14. Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, Watanabe H, et al. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res 2007;67:10727-35. (Pubitemid 350145899)
15. Yamamichi N, Yamamichi-Nishina M, Mizutani T, Watanabe H, Minoguchi S, Kobayashi N, et al. The Brm gene suppressed at the posttranscriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Oncogene 2005;24:5471-81. (Pubitemid 43080090)
16. Reisman DN, Sciarrotta J, Wang W, Funkhouser WK, Weissman BE. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis. Cancer Res 2003;63:560-6. (Pubitemid 36158131)
17. Shen H, Powers N, Saini N,, Comstock CE, Sharma A, Weaver K, et al. The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. Cancer Res 2008;68:10154-62.
18. Yamamichi-Nishina M, Ito T, Mizutani T, Yamamichi N, Watanabe H, Iba H. SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level. J Biol Chem 2003;278:7422-30. (Pubitemid 36800747)
19. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
20. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro- RNA targets. Cell 2005;120:15-20. (Pubitemid 40094598)
21. Haraguchi T, Ozaki Y, Iba H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 2009;37:e43.
22. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, et al. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 2008;14:2535-42.
23. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008;68:425-33. (Pubitemid 351380068)
24. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-45.
25. Yu T, Wang XY, Gong RG, Li A, Yang S, Cao YT, et al. The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res 2009;28:64.
26. Chen R, Alvero AB, Silasi DA, Kelly MG, Fest S, Visintin I, et al. Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. Oncogene 2008;27:4712-23.
27. Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB. A 30- untranslated region (30 UTR) induces organ adhesion by regulating miR-199a* functions. PLoS One 2009;4:e4527.
28. Ogata A, Furukawa C, Sakurai K, Iba H, Kitade Y, Ueno Y. Biaryl modification of the 50-terminus of one strand of a microRNA duplex induces strand specificity. Bioorg Med Chem Lett 2010;20:7299-302.
29. Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB. Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 2009;37:123-8.
30. Fujita S,, Iba H. Putative promoter regions of miRNA genes involved in evolutionarily conserved regulatory systems among vertebrates. Bioinformatics 2008;24:303-8. (Pubitemid 351189004)
31. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K, et al. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 2008;378:492-504.
32. Thiel G,, Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 2002;193:287-92. (Pubitemid 35265949)
33. Salah Z, Maoz M, Pizov G, Bar-Shavit R. Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer. Cancer Res 2007;67:9835-43. (Pubitemid 47621231)
34. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 1997;72:102-9. (Pubitemid 27314646)
35. Calogero A, Lombari V, De Gregorio G, Porcellini A, Ucci S, Arcella A, et al. Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma. Cancer Cell Int 2004;4:1.
36. Yamamichi N, Shimomura R, Inada K, Sakurai K, Haraguchi T, Ozaki Y, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 2009;15:4009-16.
37. Yin G, Chen R, Alvero AB, Fu H-H, Holmberg J, Glackin C, et al. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 2010;29:3545-53.
38. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009;36:61-74.
39. Iba H, Mizutani T, Ito T. SWI/SNF chromatin remodelling complex and retroviral gene silencing. Rev Med Virol 2003;13:99-110. (Pubitemid 36323673)